liver cancer tissues; normal liver tissues; liver tumor specimens; para-hepatic normal liver tissues; tumor tissues
THLE-2; Huh-7; MHCC97 H; SNU-387; HUVEC
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); angiogenesis (promotes); apoptosis (inhibits); EMT (promotes); stemness (promotes)
RNase R Treatment; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Transwell Assay; Tube Formation Assay; Annexin V/PI Flow Cytometry; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); Bioinformatics Analysis
potential targeted therapy or cure target for HCC
circ_0061395 is up-regulated in HCC tissues and cell lines and functions as an oncogenic circRNA. It promotes proliferation, migration, invasion, angiogenesis, tumor spheroid formation, EMT and xenograft tumor growth while suppressing apoptosis. Mechanistically, circ_0061395 sponges miR-1182 to increase SPOCK1 expression, forming a circ_0061395/miR-1182/SPOCK1 regulatory axis.
0.8175
Circ_0061395 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1182 sponge.
combined biological and clinical study